Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who undergo unilateral primary total joint arthroplasty
Patient willing and able to complete postoperative surveys
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up6 weeks
Awards & highlights
Study Summary
This study is evaluating whether melatonin when used as a supplement after surgery improves sleep following total joint arthroplasty.
Eligible Conditions
- Sleep Disorder
- Total Joint Replacement
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient Sleep Quality
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Group 2Active Control1 Intervention
Melatonin (6mg)
Group II: Group 1Placebo Group1 Intervention
Placebo Tablet
Find a Location
Who is running the clinical trial?
Rothman Institute OrthopaedicsLead Sponsor
121 Previous Clinical Trials
21,424 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger